Neurology® Podcast

Latest Episodes:

American Epilepsy Society Clinical Practice Guideline Aug 13, 2026

Show notes

Dr. Dara Albert talks with Dr. Daniel Freedman about the new practice guideline from the American Epilepsy Society on infantile epilepsy, highlighting key findings on medication, dietary therapy, and the importance of early surgical intervention for infants with epilepsy.

Read the related guideline here.

Disclosures can be found at Neurology.org.

Post-Traumatic Headache in Children and Genetic Risk of Migraine Aug 10, 2026

Show notes

Dr. Jessica Ailani talks with Dr. Serena Orr about the genetic risk of migraine and post-traumatic headache in children.

Read the related article in Neurology®Genetics.

Disclosures can be found at Neurology.org.

The Current State of Diagnostics for Neuroimmunologic Disorders in Africa Aug 06, 2026

Show notes

Dr. Paul Crane talks with Drs. Fiifi Duodu and Malya Sahu about neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care.

Read the related article here.

Disclosures can be found at Neurology.org.

Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA Aug 03, 2026

Show notes

Dr. Elizabeth Coon talks with Dr. Lucy Norcliffe-Kaufmann about the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

August 2026 Recall: Topics in Headache Aug 01, 2026

Show notes

The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode continues with Dr. Jennifer Robblee discussing the latest consensus on refractory migraine. In the third episode of this series, Dr. Michael Eller discusses the implications of CGRP therapies in migraine treatment. The recall concludes with a two-part discussion featuring Drs. Tesha Monteith and Peter Goadsby, who highlight major developments in headache medicine presented at the 2026 AAN Annual Meeting. Podcast links: The Best of Headache Medicine from 2025: A Year in Review Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1

Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2

Article links:

Reaching International Consensus on the Definition of Refractory Migraine Using the Delphi Method

2025 Guideline Update to Acute Treatment of Migraine for Adults in the Emergency Department

CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke

Disclosures can be found at Neurology.org.

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2 Jul 30, 2026

Show notes

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions.

For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.